Squarepoint
TARO

Squarepoint’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Squarepoint’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,656
Closed -$917K – 4805
2024
Q1 		$917K Buy
+21,656
New +$912K ﹤0.01% 2657
2019
Q4 		– Sell
-3,306
Closed -$249K – 2894
2019
Q3 		$249K Buy
3,306
+222
+7% +$18K ﹤0.01% 1987
2019
Q2 		$263K Buy
3,084
+521
+20% +$51.5K ﹤0.01% 1975
2019
Q1 		$277K Buy
+2,563
New +$255K ﹤0.01% 1809
2018
Q1 		– Sell
-25,898
Closed -$2.71M – 2244
2017
Q4 		$2.71M Buy
+25,898
New +$2.85M 0.05% 440
2017
Q3 		– Sell
-3,560
Closed -$399K – 1947
2017
Q2 		$399K Buy
+3,560
New +$402K 0.01% 1036
2016
Q2 		– Sell
-1,500
Closed -$215K – 1395
2016
Q1 		$215K Buy
+1,500
New +$213K 0.02% 971

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $3.3B AUM 20.27% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
GCM
Gladius Capital Management Chicago, Illinois $2.24B AUM 23.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Squarepoint's TARO Position: Q2 2024 in Review

Squarepoint sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 21,656 shares — an estimated $917K sold.

Squarepoint first reported a position in TARO in Q1 2016 and held it in 7 quarters. The position peaked at $2.71M in Q4 2017. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • Squarepoint reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • Squarepoint sold 21,656 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $917K.
  • Squarepoint first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2016 and held it in 7 quarters.
  • Squarepoint's Taro Pharmaceutical Industries Ltd. position peaked at $2.71M in Q4 2017.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on Squarepoint's 13F filing for Q2 2024, filed 14 Aug 2024.